Form 4: Labcorp Executive Brian J. Caveney Reports Stock Transactions

Brian J. Caveney, an executive at Labcorp Holdings Inc., reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Summary

• On February 6, 2025, Brian J. Caveney, EVP, Pres of ED, CMO & CSO of Labcorp Holdings Inc. (LH), had 670 Restricted Stock Units vest and converted to common stock.
• Concurrent with the vesting, shares were withheld to satisfy tax obligations, resulting in the disposition of 212 shares at a price of $247.74.
• Following these transactions, Caveney directly owns 28,763.6573 shares of Labcorp common stock.
• On February 7, 2025, Caveney had 517 Restricted Stock Units vest and converted to common stock.
• Concurrent with the vesting, shares were withheld to satisfy tax obligations, resulting in the disposition of 149 shares at a price of $246.27.
• Following these transactions, Caveney directly owns 29,068.6573 shares of Labcorp common stock.
• On February 7, 2025, Caveney had 112 Restricted Stock Units vest and converted to common stock.
• Concurrent with the vesting, shares were withheld to satisfy tax obligations, resulting in the disposition of 33 shares at a price of $246.27.
• Following these transactions, Caveney directly owns 29,031.6573 shares of Labcorp common stock.
• The reported transactions reflect the vesting of restricted stock units and the subsequent withholding of shares to cover tax obligations.
• The restricted stock units vest in three equal annual installments.
• The reporting person now holds 2,441 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by an executive, with no clear positive or negative implications for the company's overall outlook.

Future Outlook

The restricted stock units vest in three equal annual installments, suggesting future similar transactions.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely watched by investors for insights into management's perspective on the company's performance and future prospects.

Comparison to Industry Standards

• Stock-based compensation is a common practice in the healthcare industry to align executive incentives with shareholder value.
• Companies like Quest Diagnostics (DGX) and UnitedHealth Group (UNH) also utilize restricted stock units as part of their executive compensation packages.
• The vesting schedules and tax withholding practices observed in this filing are generally consistent with industry norms.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation matters.
• Shareholders may be interested in the executive's holdings and trading activity as an indicator of confidence in the company.

Key Dates

Keywords

Labcorp, Stock Options, Form 4, Insider Trading, Brian J. Caveney, Restricted Stock Units, Executive Compensation